- Home
- ISPC vs BJDX Comparison
ISPC vs BJDX Comparison
Compare ISPC & BJDX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ISPC
- BJDX
- Stock Information
- Founded
- ISPC 2009
- BJDX 2015
- Country
- ISPC United States
- BJDX United States
- Employees
- ISPC N/A
- BJDX N/A
- Industry
- ISPC Precision Instruments
- BJDX Medical Specialities
- Sector
- ISPC Health Care
- BJDX Health Care
- Exchange
- ISPC Nasdaq
- BJDX Nasdaq
- Market Cap
- ISPC 2.0M
- BJDX 2.1M
- IPO Year
- ISPC 2021
- BJDX 2021
- Fundamental
- Price
- ISPC $1.74
- BJDX $3.45
- Analyst Decision
- ISPC
- BJDX
- Analyst Count
- ISPC 0
- BJDX 0
- Target Price
- ISPC N/A
- BJDX N/A
- AVG Volume (30 Days)
- ISPC 120.7K
- BJDX 43.6K
- Earning Date
- ISPC 03-12-2025
- BJDX 03-27-2025
- Dividend Yield
- ISPC N/A
- BJDX N/A
- EPS Growth
- ISPC N/A
- BJDX N/A
- EPS
- ISPC N/A
- BJDX N/A
- Revenue
- ISPC $10,390,702.00
- BJDX N/A
- Revenue This Year
- ISPC $13.82
- BJDX N/A
- Revenue Next Year
- ISPC $11.76
- BJDX N/A
- P/E Ratio
- ISPC N/A
- BJDX N/A
- Revenue Growth
- ISPC 0.74
- BJDX N/A
- 52 Week Low
- ISPC $1.73
- BJDX $3.03
- 52 Week High
- ISPC $11.80
- BJDX $386.80
- Technical
- Relative Strength Index (RSI)
- ISPC 32.34
- BJDX 45.28
- Support Level
- ISPC $1.76
- BJDX $3.37
- Resistance Level
- ISPC $1.99
- BJDX $3.83
- Average True Range (ATR)
- ISPC 0.16
- BJDX 0.24
- MACD
- ISPC 0.02
- BJDX -0.00
- Stochastic Oscillator
- ISPC 2.13
- BJDX 24.00
About ISPC iSpecimen Inc.
iSpecimen Inc is a technology-driven company focused on connecting life science researchers who need human biofluids, solid tissues, and hematopoietic stem and immune cells for their research, with the available biospecimens. The company generates revenue by procuring various specimens from hospitals, laboratories, and other supply sites. Geographically, it has a presence in the Americas; Europe, the Middle East, Africa, and Asia Pacific, which majority, comes from the Americas.
About BJDX Bluejay Diagnostics Inc.
Bluejay Diagnostics Inc is a medical diagnostics company. It is developing rapid tests using whole blood using its Symphony technology platform to improve patient outcomes in critical care settings. The company's first product, the Symphony IL-6 test, is for the monitoring of disease progression in critical care settings and is a clinically established inflammatory biomarker for the assessment of the severity of infection and inflammation across many disease indications, including sepsis.